有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2R)-2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoic acid | —— | C11H9BrN2O3S |
|
—— | (2S)-2-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoate | —— | C11H8BrN2O3S- |
|
—— | (2R)-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]propanoate | —— | C7H8NO2S2- |
|
—— | (2R)-2-[(4-phenyl-1,3-thiazol-2-yl)sulfanyl]-N-propan-2-ylpropanamide | —— | C15H18N2OS2 |
|
—— | 2-[[5-(2,3-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(3-propan-2-yloxypropyl)acetamide | —— | C18H26N4O2S2 |
|
—— | (2S)-2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoic acid | —— | C11H9FN2O3S |
|
—— | (2S)-2-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoic acid | —— | C11H9BrN2O3S |
|
—— | (2R)-2-[(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)sulfanyl]propanoic acid | —— | C10H9N3O3S |
|
—— | (2S)-2-[(4-phenyl-1,3-thiazol-2-yl)sulfanyl]propanoic acid | —— | C12H11NO2S2 |
|
—— | (2R)-2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoate | —— | C11H8FN2O3S- |
|
—— | 3-[[5-(2-Fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoic acid | —— | C11H9FN2O3S |
|
—— | (2S)-2-[(4-phenyl-1,3-thiazol-2-yl)sulfanyl]-N-propan-2-ylpropanamide | —— | C15H18N2OS2 |
|
—— | 3-[[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoate | —— | C9H7N2O4S- |
|
—— | (2S)-2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoate | —— | C11H8FN2O3S- |
|
—— | (2S)-2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoic acid | —— | C11H9BrN2O3S |
|
—— | 3-[(4-Phenyl-1,3-thiazol-2-yl)sulfanyl]propanoic acid | —— | C12H11NO2S2 |
|
—— | (2R)-2-[(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)sulfanyl]propanoate | —— | C10H8N3O3S- |
|
—— | (2R)-2-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoate | —— | C11H8BrN2O3S- |
|
—— | (2S)-2-[[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoic acid | —— | C11H9FN2O3S |
|
—— | (2S)-2-[[5-(5-methyl-1,2-oxazol-3-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoic acid | —— | C9H9N3O4S |
|
—— | 2-[(5-Benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetate | —— | C11H9N2O3S- |
|
—— | (2S)-2-[[5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoate | —— | C11H8BrN2O3S- |
|
—— | (2S)-2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]propanoate | —— | C7H9N2O3S- |
|
—— | 2-[[5-(2,3-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-methyl-N-[(3-methylthiophen-2-yl)methyl]acetamide | —— | C19H22N4OS3 |
|
—— | N-(2,3-dimethylphenyl)-5-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-1,3,4-thiadiazol-2-amine | —— | C20H19N5OS2 |
|
—— | N-(furan-2-ylmethyl)-2-[[5-(5-methyl-1,2-oxazol-3-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C13H12N4O4S |
|
—— | N-(2,3-dimethylphenyl)-5-[(1-propyltetrazol-5-yl)methylsulfanyl]-1,3,4-thiadiazol-2-amine | —— | C15H19N7S2 |
|
—— | N-butyl-2-[[5-(2,3-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-methylacetamide | —— | C17H24N4OS2 |
|
—— | 1-(Azocan-1-yl)-2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]ethanone | —— | C18H24N4OS2 |
|
—— | 2-[[5-(3,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(1R)-1-(furan-2-yl)ethyl]acetamide | —— | C18H20N4O2S2 |
|
—— | 2-[(4-benzyl-5-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-(2-phenylsulfanylethyl)acetamide | —— | C20H22N4OS2 |
|
—— | 2-[[5-(3,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-methyl-N-[(3-methylthiophen-2-yl)methyl]acetamide | —— | C19H22N4OS3 |
|
—— | 1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]ethanone | —— | C20H19N3O3S2 |
|
—— | 2-[[5-(3,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-pentylacetamide | —— | C17H24N4OS2 |
|
—— | 2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(2-methylphenyl)methyl]acetamide | —— | C19H20N4OS2 |
|
—— | N-(2-cyanoethyl)-N-(furan-2-ylmethyl)-2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C19H19N5O2S2 |
|
—— | 2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(2R)-5-methylhexan-2-yl]acetamide | —— | C18H26N4OS2 |
|
—— | 2-[[5-(3,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(2-methylphenyl)methyl]acetamide | —— | C20H22N4OS2 |
|
—— | 2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N,N-dipropylacetamide | —— | C17H24N4OS2 |
|
—— | N-(4-methylphenyl)-5-[(1-propyltetrazol-5-yl)methylsulfanyl]-1,3,4-thiadiazol-2-amine | —— | C14H17N7S2 |
|
—— | 2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(2S)-5-methylhexan-2-yl]acetamide | —— | C18H26N4OS2 |
|
—— | 2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-pentylacetamide | —— | C16H22N4OS2 |
|
—— | Ethyl 2,5-dimethyl-1-[2-oxo-2-(2-phenylsulfanylethylamino)ethyl]pyrrole-3-carboxylate | —— | C19H24N2O3S |
|
—— | N-[(1S)-1-cyclopropylethyl]-2-[[5-(3,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C17H22N4OS2 |
|
—— | N-methyl-2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(3-methylthiophen-2-yl)methyl]acetamide | —— | C18H20N4OS3 |
|
—— | 2-[2-(2-oxopyrrolidin-1-yl)-1,3-thiazol-4-yl]-N-(2-phenylsulfanylethyl)acetamide | —— | C17H19N3O2S2 |
|
—— | 2-(3-benzyl-2,6-dioxopyrimidin-1-yl)-N-(2-phenylsulfanylethyl)acetamide | —— | C21H21N3O3S |
|
—— | (E)-3-[5-chloro-3-methyl-1-(2-methylpropyl)pyrazol-4-yl]-N-(2-phenylsulfanylethyl)prop-2-enamide | —— | C19H24ClN3OS |
|
—— | 4-morpholin-4-yl-4-oxo-N-(2-phenylsulfanylethyl)butanamide | —— | C16H22N2O3S |
|
—— | (Z)-N-cyclopropyl-3-phenylsulfanylprop-2-enamide | —— | C12H13NOS |
|